ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization-Reference-Cited by-同舟云学术

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization

Published:2019-08-29 Issue:2 Volume:27 Page:659-673
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:J. Nucl. Cardiol.

Author:

Dorbala Sharmila,Ando Yukio,Bokhari Sabahat,Dispenzieri Angela,Falk Rodney H.,Ferrari Victor A.,Fontana Marianna,Gheysens Olivier,Gillmore Julian D.,Glaudemans Andor W. J. M.,Hanna Mazen A.,Hazenberg Bouke P. C.,Kristen Arnt V.,Kwong Raymond Y.,Maurer Mathew S.,Merlini Giampaolo,Miller Edward J.,Moon James C.,Murthy Venkatesh L.,Quarta C. Cristina,Rapezzi Claudio,Ruberg Frederick L.,Shah Sanjiv J.,Slart Riemer H. J. A.,Verberne Hein J.,Bourque Jamieson M.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s12350-019-01761-5.pdf

Reference39 articles.

1. Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015;36:2585-94.

2. Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 2016;68:1323-41.

3. Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 2012;126:1286-300.

4. Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013;6:34-9.

5. Castano A, Narotsky DL, Hamid N, Khalique OK, Morgenstern R, DeLuca A, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017;38:2879-87.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects;Seminars in Nuclear Medicine;2024-09

2. ASNC Quality Metrics for Cardiac Amyloid Radionuclide Imaging;Journal of Nuclear Cardiology;2024-09

3. Functional Status and Quality of Life in Light-Chain Amyloidosis;JACC: Heart Failure;2024-09

4. Prognostic Value of Left Ventricular 18F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis;JACC: Cardiovascular Imaging;2024-08

5. Quantitative 99mTc-pyrophosphate Myocardial Uptake: Changes on Transthyretin Stabilization Therapy;Journal of Nuclear Cardiology;2024-08